Antigenic combinations against Francisella bacteria and related nanolipoprotein particles, compositions, methods and systems
Patent
·
OSTI ID:1986801
Provided herein are antigenic combinations and related compositions, methods and systems for immunizing a host from an infection caused by Francisella bacterium. The antigenic combination comprises an antigenic polysaccharide component from a Francisella bacterium capable of triggering a humoral immune response in an individual, a protein antigen component from the Francisella bacterium capable of triggering a cellular immune response in the individual, and an adjuvant, the antigenic Francisella polysaccharide component, the Francisella protein antigen component and the adjuvant are in a suitable amount to immunize an individual against the Francisella bacterium.
- Research Organization:
- Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States); Univ. of New Mexico, Albuquerque, NM (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC52-07NA27344
- Assignee:
- Lawrence Livermore National Security, LLC (Livermore, CA); Regents of the University of New Mexico (Albuquerque, NM)
- Patent Number(s):
- 11,491,215
- Application Number:
- 16/543,463
- OSTI ID:
- 1986801
- Resource Relation:
- Patent File Date: 08/16/2019
- Country of Publication:
- United States
- Language:
- English
Similar Records
Comparative phosphoproteomics reveals components of host cell invasion and post-transcriptional regulation during Francisella infection
Induction of Protection in Mice against a Chlamydia muridarum Respiratory Challenge by a Vaccine Formulated with the Major Outer Membrane Protein in Nanolipoprotein Particles
Nanolipoprotein Particles (NLPs) as Versatile Vaccine Platforms for Co-delivery of Multiple Adjuvants with Subunit Antigens from Burkholderia spp. and F. tularensis - Annual Technical Report
Journal Article
·
Sun Sep 22 00:00:00 EDT 2013
· Molecular and Cellular Proteomics, 12(11):3297-3309
·
OSTI ID:1986801
+8 more
Induction of Protection in Mice against a Chlamydia muridarum Respiratory Challenge by a Vaccine Formulated with the Major Outer Membrane Protein in Nanolipoprotein Particles
Journal Article
·
Wed Jul 07 00:00:00 EDT 2021
· Vaccines
·
OSTI ID:1986801
+6 more
Nanolipoprotein Particles (NLPs) as Versatile Vaccine Platforms for Co-delivery of Multiple Adjuvants with Subunit Antigens from Burkholderia spp. and F. tularensis - Annual Technical Report
Technical Report
·
Thu Apr 16 00:00:00 EDT 2015
·
OSTI ID:1986801